$5.8 M

Universal Biosensors Revenue Q2, 2018
Universal Biosensors Gross profit (Q2, 2018)5.6 M
Universal Biosensors Gross profit margin (Q2, 2018), %97.1%
Universal Biosensors Net income (Q2, 2018)-557.5 K
Universal Biosensors Cash, 31-Dec-201620.4 M

Universal Biosensors Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

15.1m9.5m16.8m18.8m25.2m

Revenue growth, %

(37%)76%12%

Cost of goods sold

1.2m242.5k244.1k155.0k936.2k

Gross profit

13.9m9.3m16.5m18.7m24.3m

Gross profit Margin, %

92%97%99%99%96%

R&D expense

15.5m17.1m19.8m15.0m10.8m

General and administrative expense

6.2m5.6m6.0m6.4m6.7m

Operating expense total

21.7m22.8m25.8m21.4m17.5m

Depreciation and amortization

2.1m

EBIT

(18.2m)(13.8m)(10.4m)(3.7m)

EBIT margin, %

(121%)(145%)(62%)(20%)

Interest expense

22.6k15.9k15.1k8.4k9.6k

Interest income

500.0k260.9k242.6k201.1k172.4k

Pre tax profit

(11.6m)(9.3m)(6.6m)

Net Income

(11.6m)(9.3m)(6.6m)

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q2, 2015Q2, 2016Q3, 2016Q1, 2018Q2, 2018

Revenue

1.4m1.5m2.1m4.4m5.4m3.3m7.7m5.8m

Cost of goods sold

16.1k6.8k127.1k180.0k261.1k166.1k

Gross profit

1.3m1.5m2.0m4.2m7.4m5.6m

Gross profit Margin, %

99%100%94%96%97%97%

R&D expense

4.9m4.3m4.7m5.0m2.9m3.9m3.9m2.8m

General and administrative expense

1.4m1.7m1.5m1.5m1.0m1.4m1.8m2.0m

Operating expense total

6.3m6.0m6.2m6.5m3.9m5.4m5.7m10.4m

Depreciation and amortization

533.2k534.7k

EBIT

(5.0m)(4.4m)(4.5m)(2.6m)(2.1m)

EBIT margin, %

(367%)(294%)(215%)(59%)(64%)

Interest expense

6.4k4.8k4.8k7.1k2.8k2.8k

Interest income

54.3k29.5k103.4k43.2k25.6k89.7k44.8k145.1k

Pre tax profit

(3.6m)(3.4m)(1.9m)(1.3m)(2.2m)

Net Income

(3.6m)(3.4m)(1.9m)(1.3m)(2.2m)83.8k(557.5k)

Universal Biosensors Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

23.7m16.3m14.4m20.4m

Accounts Receivable

2.2m3.8m3.2m4.8m

Inventories

4.2k839.3k

Current Assets

35.8m30.3m28.8m35.2m

PP&E

15.9m14.3m12.9m11.5m

Total Assets

54.6m47.5m45.0m50.0m

Accounts Payable

974.8k480.5k894.7k547.3k

Current Liabilities

5.4m6.5m4.8m5.9m

Non-Current Liabilities

19.5m21.3m26.9m30.8m

Total Liabilities

24.9m27.8m31.7m36.7m

Additional Paid-in Capital

95.0m94.3m94.4m93.2m

Retained Earnings

(53.4m)(65.0m)(74.3m)(80.9m)

Total Equity

29.7m19.7m13.3m13.3m

Financial Leverage

1.8 x2.4 x3.4 x3.8 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014

Cash

19.5m15.9m19.8m

Accounts Receivable

2.1m1.8m2.0m

Inventories

261.9k393.7k

Current Assets

32.2m29.6m29.0m

PP&E

15.6m15.3m14.8m

Total Assets

50.7m47.8m46.6m

Accounts Payable

991.3k1.7m957.1k

Current Liabilities

5.7m6.5m6.0m

Non-Current Liabilities

19.1m18.8m20.1m

Total Liabilities

24.9m25.3m26.0m

Additional Paid-in Capital

94.8m94.7m94.7m

Retained Earnings

(65.0m)(65.0m)(65.0m)

Total Equity

25.9m22.5m20.6m

Financial Leverage

2 x2.1 x2.3 x

Universal Biosensors Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(11.6m)(9.3m)(6.6m)1.3m(764.7k)

Depreciation and Amortization

2.5m2.5m2.7m2.6m2.6m

Accounts Receivable

(1.7m)450.7k

Inventories

3.6m126.1k42.2k(484.0k)177.1k

Accounts Payable

(1.7m)3.3m2.7m(299.6k)(1.0m)

Cash From Operating Activities

(16.6m)(5.4m)(527.8k)

Purchases of PP&E

(159.4k)(955.3k)(1.3m)(1.2m)(1.3m)

Cash From Investing Activities

(159.4k)(947.4k)(1.3m)(1.3m)(1.0m)

Cash From Financing Activities

16.3m(1.8m)(1.4m)45.2k(368.9k)
Report incorrect company information